engleski

Comparative analysis of price dynamics of original and generic simvastatine and atorvastatine and the discount factor applicable in the Croatia

The starting point of this analysis is a scientifically established fact that the real price of brand name and generic drugs drops according to the length of the implementation period. This fact was tested on the example of the 25 most prescribed drugs in the Republic of Croatia in the period of 2008 to 2012., and especially on the two most prescribed drugs groups from the ATC C-10 drug group (simvastatine and atorvastatine). The aim of this research is to determine the difference between the prices of the 25 most prescribed drugs in the Republic of Croatia and the most prescribed drugs group from the C-10 group (simvastatine and atorvastatine), and also to determine whether there are differences in the actual dynamics of drug prices in comparison to the estimated discount rate account using CAPM (Capital Asset Price Model). It will also be determined whether there are differences in population dynamics, current prices and real prices adjusted for the dynamics of the producer prices of the pharmaceutical products and preparations (statistical data). C-10 statine, real prices, discount rate

C-10 statine ; real prices ; discount rate

nije evidentirano